Star Lake Bioscience Co (SHSE:600866) Cyclically Adjusted FCF per Share: ¥0.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600866 Star Lake Bioscience Co Inc SHSE:600866
71 GF Score
Price ¥4.52
GF Value ¥5.88
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Star Lake Bioscience Co Cyclically Adjusted FCF per Share?

Star Lake Bioscience Co SHSE:600866 -1.53% 71 Cyclically Adjusted FCF per Share is ¥0.20 as of Mar. 2026. GuruFocus rates SHSE:600866 with a GF Score™ of 71/100 and a GF Value™ of ¥5.88 (Modestly Undervalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Star Lake Bioscience Co's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.626. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Star Lake Bioscience Co's average Cyclically Adjusted FCF Growth Rate was -31.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 105.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Star Lake Bioscience Co was 105.40% per year. The lowest was -115.40% per year. And the median was -3.20% per year.

As of today (2026-08-04), Star Lake Bioscience Co's current stock price is ¥4.52. Star Lake Bioscience Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.20. Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF of today is 22.60.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Star Lake Bioscience Co was 230.33. The lowest was 20.79. And the median was 27.30.


Star Lake Bioscience Co  (SHSE:600866) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.52/0.20
=22.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Star Lake Bioscience Co was 230.33. The lowest was 20.79. And the median was 27.30.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Star Lake Bioscience Co Cyclically Adjusted FCF per Share Related Terms


Star Lake Bioscience Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Star Lake Bioscience Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Lake Bioscience Co Cyclically Adjusted FCF per Share Chart

Star Lake Bioscience Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.20 0.03 0.16 0.28 0.26

Star Lake Bioscience Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.28 0.32 0.26 0.20

SHSE:600866 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600866
71GF Score
Star Lake Bioscience Co Inc SHSE:600866
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Star Lake Bioscience Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Star Lake Bioscience Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.626/116.3033*116.3033
=-0.626

Current CPI (Mar. 2026) = 116.3033.

Star Lake Bioscience Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.043 101.400 0.049
201609 -0.050 102.400 -0.057
201612 0.016 102.600 0.018
201703 -0.029 103.200 -0.033
201706 0.056 103.100 0.063
201709 -0.012 104.100 -0.013
201712 -0.001 104.500 -0.001
201803 -0.005 105.300 -0.006
201806 -0.016 104.900 -0.018
201809 -0.014 106.600 -0.015
201812 0.083 106.500 0.091
201903 0.079 107.700 0.085
201906 0.083 107.700 0.090
201909 -0.031 109.800 -0.033
201912 -0.053 111.200 -0.055
202003 0.001 112.300 0.001
202006 -0.057 110.400 -0.060
202009 -0.093 111.700 -0.097
202012 0.095 111.500 0.099
202103 -0.098 112.662 -0.101
202106 -0.069 111.769 -0.072
202109 0.022 112.215 0.023
202112 -0.073 113.108 -0.075
202203 0.027 114.335 0.027
202206 0.182 114.558 0.185
202209 1.161 115.339 1.171
202212 -0.271 115.116 -0.274
202303 -0.442 115.116 -0.447
202306 0.667 114.558 0.677
202309 0.732 115.339 0.738
202312 0.037 114.781 0.037
202403 -0.142 115.227 -0.143
202406 0.332 114.781 0.336
202409 0.763 115.785 0.766
202412 0.105 114.893 0.106
202503 0.058 115.116 0.059
202506 -0.224 114.907 -0.227
202509 0.349 115.471 0.352
202512 -0.632 115.832 -0.635
202603 -0.626 116.303 -0.626

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.20 mean?
Star Lake Bioscience Co (SHSE:600866) has a Cyclically Adjusted FCF per Share of ¥0.20 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Star Lake Bioscience Co and its competitors.
Is Star Lake Bioscience Co's Cyclically Adjusted FCF per Share too high?
Star Lake Bioscience Co's current Cyclically Adjusted FCF per Share is ¥0.20. Overall, Star Lake Bioscience Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Star Lake Bioscience Co's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Star Lake Bioscience Co's Cyclically Adjusted FCF per Share of ¥0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Star Lake Bioscience Co and its competitors. Star Lake Bioscience Co's current Cyclically Adjusted FCF per Share is ¥0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Lake Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Star Lake Bioscience Co (SHSE:600866) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.88, compared to a current price of ¥4.52 — trading 23.1% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.20. Star Lake Bioscience Co's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Star Lake Bioscience Co (SHSE:600866), the current Cyclically Adjusted FCF per Share is ¥0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Star Lake Bioscience Co (SHSE:600866) Overvalued in 2026?

Based on GuruFocus' analysis, Star Lake Bioscience Co stock appears to be undervalued. The current stock price of ¥4.52 is trading 23.1% below its estimated GF Value™ of ¥5.88. GuruFocus considers Star Lake Bioscience Co to be Modestly Undervalued.

Key valuation signals for SHSE:600866:

  • Cyclically Adjusted FCF per Share: ¥0.20
  • GF Value™: ¥5.88 vs. price of ¥4.52 (23.1% below fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600866 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Star Lake Bioscience Co Business Description

Address No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
71GF Score

Get the complete analysis for SHSE:600866

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.52
Price
¥5.88
GF Value